Locations worldwide
"Globalization" no longer implies "westernization". As a global company our strategic investments are influenced by the fundamental eastward shift in the world economy. Projects in China are typically approached systematically, strategically and with long-term horizon – e.g. in Shanghai Novartis specializes in basic research and development of new drugs to treat diseases that are highly prevalent in China.
Novartis Institute for Tropical Diseases (NITD) in Singapore
Novartis Institutes for BioMedical Research (NIBR) facility in Shanghai, China
Artist rendering of the new Novartis Institutes for BioMedical Research (NIBR) facility in Shanghai, China
Pharmaceutical development new Changshu facility, China
You may use the multimedia material provided in this section for commercial purposes only in relation to Novartis. These images must not be modified in any way and each item must have the copyright acknowledgement of Novartis AG (© Novartis AG).
